NASDAQ:ODTX Odyssey Therapeutics (ODTX) Stock Price, News & Analysis $17.01 -0.91 (-5.08%) As of 05/29/2026 04:00 PM Eastern Add Share Share Stock Analysis Stock AnalysisChartInsider TradesSEC FilingsShort InterestTrendsBuy This Stock About Odyssey Therapeutics Stock (NASDAQ:ODTX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Odyssey Therapeutics alerts:Sign Up Key Stats Today's Range$16.86▼$18.0250-Day Range N/A52-Week Range$15.35▼$20.30Volume165,302 shsAverage Volume344,622 shsMarket Capitalization$802.43 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Read More Receive ODTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Odyssey Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ODTX Stock News HeadlinesOdyssey Therapeutics IncMay 26, 2026 | money.usnews.comA Boston biotech tried to go public last year but pulled back. Now it’s valued at nearly $1BMay 16, 2026 | finance.yahoo.comThe REAL reason for the SpaceX IPOTech investor Jeff Brown - former senior executive at Qualcomm, Juniper Networks, and NXP Semiconductors - says one chipmaker 148 times smaller than NVIDIA is positioned to supply Elon Musk with 5 billion chips over the next two years. Brown believes Musk's 'Orbital AI' technology is the driving force behind the xAI-SpaceX merger and the planned SpaceX IPO - and that a single Musk-linked company could represent a rare $12.8 trillion opportunity for investors who move early.May 30 at 1:00 AM | Brownstone Research (Ad)Insider Buying: Odyssey Therapeutics (NASDAQ:ODTX) Major Shareholder Buys 1,388,889 Shares of StockMay 14, 2026 | insidertrades.comInsider Buying: Odyssey Therapeutics (NASDAQ:ODTX) Director Buys $19,999,998.00 in StockMay 13, 2026 | insidertrades.comHealthcare IPOs Raise $4.7 Billion As Odyssey, Mobia Debuts SlipMay 12, 2026 | finance.yahoo.comInsider Buying: Odyssey Therapeutics (NASDAQ:ODTX) CFO Acquires 1,000 Shares of StockMay 12, 2026 | insidertrades.comSee More Headlines ODTX Stock Analysis - Frequently Asked Questions How have ODTX shares performed this year? Odyssey Therapeutics' stock was trading at $17.45 at the beginning of 2026. Since then, ODTX shares have decreased by 2.5% and is now trading at $17.01. When did Odyssey Therapeutics IPO? Odyssey Therapeutics (ODTX) raised $264 million in an initial public offering (IPO) on Friday, May 8th 2026. The company issued 15,500,000 shares at $16.00-$18.00 per share. When does the company's quiet period expire? Odyssey Therapeutics's quiet period expires on Wednesday, June 17th. Odyssey Therapeutics had issued 15,500,000 shares in its public offering on May 8th. The total size of the offering was $279,000,000 based on an initial share price of $18.00. During the company's quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company. How do I buy shares of Odyssey Therapeutics? Shares of ODTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ODTX CIK1882782 WebN/A PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$2.98 million Price / Sales269.63 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares47,174,000Free FloatN/AMarket Cap$802.43 million OptionableN/A BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NASDAQ:ODTX) was last updated on 5/30/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredPresident Trump just sparked a stock market MELT UPThe real reason Musk, Huang, Cook, and Fink just flew to Beijing Last week, the CEOs of Nvidia, Apple, Spac...Stansberry Research | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredSkip the Line Opportunity: The SpaceX IPOFormer tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...Brownstone Research | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Odyssey Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Odyssey Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.